SF
AGN

Scott Ferguson’s Allergan Inc AGN Stock Holding History

Scott Ferguson’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-509,800
Closed -$90.8M – 10
2014
Q3 		$90.8M Buy
509,800
+19,800
+4% +$3.29M 10.13% 4
2014
Q2 		$82.9M Buy
+490,000
New +$76.3M 8.47% 5

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $19.5B AUM 2.08% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Scott Ferguson's AGN Position: Q4 2014 in Review

Scott Ferguson sold out of Allergan Inc (AGN) in Q4 2014, closing a stake of 509,800 shares — an estimated $90.8M sold.

Scott Ferguson first reported a position in AGN in Q2 2014 and held it in 2 quarters. The position peaked at $90.8M in Q3 2014. 819 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Scott Ferguson reported no remaining Allergan Inc position as of Q4 2014 after selling out during the quarter.
  • Scott Ferguson sold 509,800 Allergan Inc shares in Q4 2014, an estimated $90.8M.
  • Scott Ferguson first reported a position in Allergan Inc in Q2 2014 and held it in 2 quarters.
  • Scott Ferguson's Allergan Inc position peaked at $90.8M in Q3 2014.
  • 819 funds tracked by Wall St. Rank held Allergan Inc as of Q4 2014.

Based on Sachem Head Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.